Ranking pharmaceutical companies and new drugs on ethics, transparency and population health criteria

Trent Hall, Room 040

Ranking pharmaceutical companies and new drugs on ethics, transparency and population health criteria

Trent Hall, Room 040

Join us for a Global Health Exchange lecture, sponsored by DGHI. This event is free and open to the public so please spread the word to your colleagues and friends. Light lunch will be served.

About the lecture:
This talk will landscape the state of ethics and transparency in the pharmaceutical industry, focusing on how medicines and vaccines are researched, developed, marketed and made globally accessible. It will also propose a remedy (the OpenPharma Index) to help address genuine and widespread ethics and governance problems and build a more trustworthy healthcare innovation sector. 

About the Speaker:
Jennifer E. Miller, PhD, is a fellow in Harvard University’s Edmond J. Safra Center for Ethics and Duke University’s Kenan Institute for Ethics. Previously, she taught in Columbia University's Bioethics and Cross Cultural Education Program and in Fordham University's Schools of Business while completing her doctorate in bioethics at Regina Apostolorum Pontifical University.

Miller also holds a Bachelor’s of Science degree in physics and has served on the CDC’s Taskforces for Pediatric Emergency Mass Critical Care, the AMA’s Advanced Disaster Life Support Education Consortium, as a consultant to the United Nations ECOSOC, as the Founding President of the nonprofit Bioethics International, and as a biweekly pundit for Fox News.

Currently, Miller explores the ethics, trustworthiness and governance of healthcare innovation from normative, empirical and qualitative perspectives. She created and is piloting a rating system that ranks pharmaceutical companies on specific criteria (at the intersection of ethics and population health) to help recognize good ethics practices in companies and incentivize reform where needed.